GC Genome are committed to putting individuals in control of health and well-being.
Our compassionate approach goes beyond diagnosis.
We support and equip patients to make informed decisions,
actively engage in their treatment, and become advocates for their own health journey.

GC Genome was founded in 2013 as a subsidiary focusing on genomic business in GC group, one of the leading healthcare companies in the world. Positioning R&D as a strategic priority, we are the number one CAP-accredited clinical lab in South Korea. And we have been building firm relationships with University/National hospitals and have shown continuous accelerated growth in test volumes with strong momentum.

Our science heritage aim to uncovering solutions for patients and advancing the development of genomic diagnostics with the potential to enhance the quality of people’s lives.
Our emphasis lies in unwavering focus and the relentless pursuit of excellence.

Explore the most recent press releases and media assets from the field of genetic analysis research at the global healthcare and GC Genome.

We engage in partnerships with innovators to push forward great science and continually seek new partners that are actively researching bold scientific ideas, capabilities and technologies that have the potential to bring innovative treatments to patients in need.